Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.76
-0.50 (-4.44%)
At close: Aug 15, 2025, 3:59 PM
10.78
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aardvark Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
16K 97K 110K
Gross Profit
-16K -97K -110K
Operating Income
-22.79M -7.42M -11.36M
Interest Income
2.41M 1.42M 120K
Pretax Income
-20.59M -7.21M -13.56M
Net Income
-20.59M -7.21M -13.56M
Selling & General & Admin
5.3M 2.17M 2.7M
Research & Development
17.36M 4.48M 7.17M
Other Expenses
117K 762K 1.49M
Operating Expenses
22.79M 7.42M 11.36M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
22.79M 7.42M 11.36M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
12.91M 12.91M 9.73M
Shares Outstanding (Diluted)
12.91M 12.91M 9.73M
EPS (Basic)
-1.59 -0.56 -1.39
EPS (Diluted)
-1.59 -0.56 -1.39
EBITDA
-20.57M -7.32M -10.25M
EBIT
-20.59M -7.42M -10.36M
Depreciation & Amortization
16K 97K 110K